Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hanaki

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Ryoikibetsu Shokogun Shirizu|March 24, 1999
[Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)]K Kuwahara, H Hanaki, K Hiramatsu
Journal of Chemotherapy (Florence, Italy)|April 1, 1997
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infectionsS Nomura, H Hanaki, A Nagayama
Nihon Kyobu Shikkan Gakkai Zasshi|May 1, 1986
[A case of minocycline-induced pneumonitis]H Kuroki, I Usami, H Hanaki
Ophthalmic Research|January 1, 1996
Evaluation of transparency and barrier function of the cornea by Scheimpflug imagesK Kitagawa, Y Sakamoto, K Sasaki, et al.
The Japanese Journal of Antibiotics|December 4, 1998
[A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA)]H Hanaki, Y Inaba, K Sasaki, et al.
The Journal of Antibiotics|August 1, 1995
Structure-activity relationships of 2-thioisocephem against methicillin-resistant Staphylococcus aureusH Hanaki, H Akagi, M Yasui, et al.
Chemotherapy|January 1, 1997
Antibacterial activity of TOC-50, a new parenteral cephalosporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniaeS Nomura, H Hanaki, T Furukawa, et al.
Chemotherapy|April 18, 2001
Improvement of water-soluble cephalosporin derivatives having antibacterial activity against methicillin-resistant Staphylococcus aureusH Hanaki, S Nomura, H Akagi, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycinN Aritaka, H Hanaki, L Cui, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 24, 1999
[In vitro susceptibility of Streptococcus agalactiae clinical isolates to beta-lactam antibiotics]N Ikeda, H Hanaki, K Hiramatsu, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Ryoikibetsu Shokogun Shirizu|March 24, 1999
[Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)]K Kuwahara, H Hanaki, K Hiramatsu
Journal of Chemotherapy (Florence, Italy)|April 1, 1997
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infectionsS Nomura, H Hanaki, A Nagayama
Nihon Kyobu Shikkan Gakkai Zasshi|May 1, 1986
[A case of minocycline-induced pneumonitis]H Kuroki, I Usami, H Hanaki
Ophthalmic Research|January 1, 1996
Evaluation of transparency and barrier function of the cornea by Scheimpflug imagesK Kitagawa, Y Sakamoto, K Sasaki, et al.
The Japanese Journal of Antibiotics|December 4, 1998
[A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA)]H Hanaki, Y Inaba, K Sasaki, et al.
The Journal of Antibiotics|August 1, 1995
Structure-activity relationships of 2-thioisocephem against methicillin-resistant Staphylococcus aureusH Hanaki, H Akagi, M Yasui, et al.
Chemotherapy|January 1, 1997
Antibacterial activity of TOC-50, a new parenteral cephalosporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniaeS Nomura, H Hanaki, T Furukawa, et al.
Chemotherapy|April 18, 2001
Improvement of water-soluble cephalosporin derivatives having antibacterial activity against methicillin-resistant Staphylococcus aureusH Hanaki, S Nomura, H Akagi, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycinN Aritaka, H Hanaki, L Cui, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 24, 1999
[In vitro susceptibility of Streptococcus agalactiae clinical isolates to beta-lactam antibiotics]N Ikeda, H Hanaki, K Hiramatsu, et al.
Pageof 5